![Shamik Parikh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 354 527 $ in data 31/05/2026
Shamik J.
Parikh is currently Chief Medical Officer at Humacyte, Inc. since 2022.
Formerly, Dr. Parikh was Vice President & Head-Patient Safety Center at AstraZeneca PLC from 2016 to 2022 and Director-Clinical Development & Medical Affairs at GlaxoSmithKline LLC from 2003 to 2005.
Education includes a doctorate from Topiwala National Medical College & BYL Nair.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
HUMACYTE, INC. 0,12% | 18/05/2026 | 272.713 ( 0,12% ) | 354 527 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| HUMACYTE, INC. | Direttore Tecnico/Scientifico/R&S | 05/04/2022 |
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2022 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/06/2005 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Topiwala National Medical College & BYL Nair
 Topiwala National Medical College & BYL Nair Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Humacyte, Inc.
 Humacyte, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
